Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
CEA - Prognostic Marker for Breast Cancer: GOHEL, Dr HARDIK R: 9781794454927: Amazon.com: Books
2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram
K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram
Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia - The American Journal of Emergency Medicine
HE4 is an independent prognostic marker in endometrial cancer patients - Gynecologic Oncology
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy - Radiotherapy and Oncology
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology
Prognostic and predictive factors for lung cancer | European Respiratory Society
Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review - European Journal of Obstetrics and Gynecology and Reproductive Biology
Prognostic markers on Breast Cancer
Almost all articles on cancer prognostic markers report statistically significant results - European Journal of Cancer
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions - Gynecologic Oncology
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences
PLOS ONE: MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
PLOS ONE: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
Table III. | SPARC mRNA Expression as a Prognostic Marker for Pancreatic Adenocarcinoma Patients | Anticancer Research
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
PLOS ONE: Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer